Rank | Gene Set | Z-score |
---|---|---|
1 | ribosomal small subunit assembly (GO:0000028) | 5.30972342 |
2 | viral transcription (GO:0019083) | 5.13047549 |
3 | translational termination (GO:0006415) | 4.99455032 |
4 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.93830747 |
5 | DNA deamination (GO:0045006) | 4.90849276 |
6 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.86066193 |
7 | DNA strand elongation (GO:0022616) | 4.65991071 |
8 | ribosomal small subunit biogenesis (GO:0042274) | 4.55741400 |
9 | translational elongation (GO:0006414) | 4.50110115 |
10 | maturation of SSU-rRNA (GO:0030490) | 4.47763652 |
11 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.38383858 |
12 | cotranslational protein targeting to membrane (GO:0006613) | 4.26734726 |
13 | protein targeting to ER (GO:0045047) | 4.26451833 |
14 | telomere maintenance via recombination (GO:0000722) | 4.22291140 |
15 | translational initiation (GO:0006413) | 4.21581529 |
16 | formation of translation preinitiation complex (GO:0001731) | 4.21262917 |
17 | DNA replication initiation (GO:0006270) | 4.13765804 |
18 | DNA unwinding involved in DNA replication (GO:0006268) | 4.10226783 |
19 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.09810161 |
20 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.03409547 |
21 | ribosomal large subunit biogenesis (GO:0042273) | 4.02685573 |
22 | protein localization to endoplasmic reticulum (GO:0070972) | 4.02092353 |
23 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.00083986 |
24 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.96139627 |
25 | viral life cycle (GO:0019058) | 3.95887330 |
26 | cellular protein complex disassembly (GO:0043624) | 3.91815392 |
27 | mitotic recombination (GO:0006312) | 3.90449617 |
28 | regulation of mitochondrial translation (GO:0070129) | 3.76130081 |
29 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.66805111 |
30 | protein localization to kinetochore (GO:0034501) | 3.65073269 |
31 | telomere maintenance via telomere lengthening (GO:0010833) | 3.62287917 |
32 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.57850791 |
33 | ATP synthesis coupled proton transport (GO:0015986) | 3.57850791 |
34 | DNA replication checkpoint (GO:0000076) | 3.56953534 |
35 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.56659759 |
36 | nucleobase biosynthetic process (GO:0046112) | 3.50759401 |
37 | protein complex disassembly (GO:0043241) | 3.49467839 |
38 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.45912812 |
39 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.45912812 |
40 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.36940618 |
41 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.35229160 |
42 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.34931466 |
43 | translation (GO:0006412) | 3.32297327 |
44 | macromolecular complex disassembly (GO:0032984) | 3.30556336 |
45 | purine nucleobase biosynthetic process (GO:0009113) | 3.26550146 |
46 | proteasome assembly (GO:0043248) | 3.25586434 |
47 | ubiquinone biosynthetic process (GO:0006744) | 3.21154545 |
48 | cullin deneddylation (GO:0010388) | 3.19387029 |
49 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.18167121 |
50 | respiratory electron transport chain (GO:0022904) | 3.13624933 |
51 | rRNA processing (GO:0006364) | 3.12682271 |
52 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.12364185 |
53 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.10656675 |
54 | protein localization to chromosome, centromeric region (GO:0071459) | 3.10630058 |
55 | protein deneddylation (GO:0000338) | 3.09509892 |
56 | protein complex biogenesis (GO:0070271) | 3.09432351 |
57 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.09283548 |
58 | immunoglobulin mediated immune response (GO:0016064) | 3.09261345 |
59 | ribosome biogenesis (GO:0042254) | 3.05937196 |
60 | IMP biosynthetic process (GO:0006188) | 3.05719558 |
61 | electron transport chain (GO:0022900) | 3.05461133 |
62 | chaperone-mediated protein transport (GO:0072321) | 3.05157492 |
63 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.04669034 |
64 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.03380613 |
65 | ncRNA 3-end processing (GO:0043628) | 3.03341665 |
66 | mitotic nuclear envelope disassembly (GO:0007077) | 3.02727271 |
67 | mRNA catabolic process (GO:0006402) | 3.01439690 |
68 | rRNA metabolic process (GO:0016072) | 2.98994246 |
69 | spliceosomal snRNP assembly (GO:0000387) | 2.98758295 |
70 | positive regulation of ligase activity (GO:0051351) | 2.97658253 |
71 | rRNA modification (GO:0000154) | 2.95484711 |
72 | RNA catabolic process (GO:0006401) | 2.94491553 |
73 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.92737573 |
74 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.91868332 |
75 | CENP-A containing nucleosome assembly (GO:0034080) | 2.91004678 |
76 | response to peptidoglycan (GO:0032494) | 2.90648422 |
77 | deoxyribose phosphate catabolic process (GO:0046386) | 2.88957278 |
78 | chromatin remodeling at centromere (GO:0031055) | 2.88770716 |
79 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.88447932 |
80 | pseudouridine synthesis (GO:0001522) | 2.86606197 |
81 | deoxyribonucleotide catabolic process (GO:0009264) | 2.86182020 |
82 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.85394960 |
83 | protein targeting to mitochondrion (GO:0006626) | 2.84473682 |
84 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.82904948 |
85 | DNA replication-independent nucleosome organization (GO:0034724) | 2.82017769 |
86 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.82017769 |
87 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.81963484 |
88 | regulation of protein heterodimerization activity (GO:0043497) | 2.81893977 |
89 | ribosome assembly (GO:0042255) | 2.81337988 |
90 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.81151320 |
91 | negative regulation of ligase activity (GO:0051352) | 2.81151320 |
92 | ubiquinone metabolic process (GO:0006743) | 2.80298457 |
93 | B cell mediated immunity (GO:0019724) | 2.78393743 |
94 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.77317585 |
95 | * metallo-sulfur cluster assembly (GO:0031163) | 2.75275081 |
96 | * iron-sulfur cluster assembly (GO:0016226) | 2.75275081 |
97 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.74404500 |
98 | membrane disassembly (GO:0030397) | 2.74290421 |
99 | nuclear envelope disassembly (GO:0051081) | 2.74290421 |
100 | response to interferon-beta (GO:0035456) | 2.74081772 |
101 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.73309968 |
102 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.72960037 |
103 | protein targeting to membrane (GO:0006612) | 2.72896037 |
104 | folic acid metabolic process (GO:0046655) | 2.72858239 |
105 | mitotic metaphase plate congression (GO:0007080) | 2.72386156 |
106 | telomere maintenance (GO:0000723) | 2.72328562 |
107 | telomere organization (GO:0032200) | 2.71350662 |
108 | GDP-mannose metabolic process (GO:0019673) | 2.71266303 |
109 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.70850920 |
110 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.70850920 |
111 | IMP metabolic process (GO:0046040) | 2.69164781 |
112 | cell cycle G1/S phase transition (GO:0044843) | 2.68999149 |
113 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.68999149 |
114 | cytochrome complex assembly (GO:0017004) | 2.68676570 |
115 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.68418809 |
116 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.67813237 |
117 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.67813237 |
118 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.67813237 |
119 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.67435868 |
120 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.66959534 |
121 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.66459646 |
122 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.66459646 |
123 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.65159862 |
124 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.63690995 |
125 | cellular component biogenesis (GO:0044085) | 2.62764436 |
126 | DNA duplex unwinding (GO:0032508) | 2.62751198 |
127 | DNA geometric change (GO:0032392) | 2.62725993 |
128 | regulation of ligase activity (GO:0051340) | 2.61043645 |
129 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.60941964 |
130 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.60738945 |
131 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.60640752 |
132 | translesion synthesis (GO:0019985) | 2.60350380 |
133 | establishment of integrated proviral latency (GO:0075713) | 2.59200574 |
134 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.59117345 |
135 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.59117345 |
136 | negative regulation of RNA splicing (GO:0033119) | 2.58468438 |
137 | kinetochore organization (GO:0051383) | 2.57872524 |
138 | establishment of protein localization to mitochondrion (GO:0072655) | 2.57354231 |
139 | mannosylation (GO:0097502) | 2.56955087 |
140 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.56652200 |
141 | quinone biosynthetic process (GO:1901663) | 2.56004611 |
142 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.55657440 |
143 | regulation of T cell tolerance induction (GO:0002664) | 2.55547693 |
144 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.55430490 |
145 | NADH dehydrogenase complex assembly (GO:0010257) | 2.55430490 |
146 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.55430490 |
147 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.52021201 |
148 | regulation of cellular amine metabolic process (GO:0033238) | 2.51502865 |
149 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.51082427 |
150 | protein localization to mitochondrion (GO:0070585) | 2.50683386 |
151 | positive regulation of cell cycle arrest (GO:0071158) | 2.48316806 |
152 | respiratory chain complex IV assembly (GO:0008535) | 2.47318459 |
153 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.46702654 |
154 | nucleotide salvage (GO:0043173) | 2.46654561 |
155 | negative regulation of protein ubiquitination (GO:0031397) | 2.46070127 |
156 | positive regulation of T cell apoptotic process (GO:0070234) | 2.43173063 |
157 | pentose metabolic process (GO:0019321) | 2.42956528 |
158 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.39186178 |
159 | purine nucleotide salvage (GO:0032261) | 2.38798441 |
160 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.38402397 |
161 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.37232649 |
162 | oxidative phosphorylation (GO:0006119) | 2.36670687 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.61213902 |
2 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.97290741 |
3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.92481675 |
4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.14938080 |
5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.98872325 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.79105543 |
7 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.67219968 |
8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.66721444 |
9 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.66429350 |
10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.65731428 |
11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.61675355 |
12 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.59346785 |
13 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.57601739 |
14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.54574231 |
15 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.51912506 |
16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.39395571 |
17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.25572975 |
18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.22987812 |
19 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.22284026 |
20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.15910414 |
21 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.11856486 |
22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.11455987 |
23 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.10509917 |
24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.07685504 |
25 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.04678207 |
26 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.03933768 |
27 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.01308949 |
28 | MYC_22102868_ChIP-Seq_BL_Human | 1.96443145 |
29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.89938976 |
30 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.89089765 |
31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.87115833 |
32 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87109677 |
33 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.82779040 |
34 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.74970975 |
35 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.68991848 |
36 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.66835719 |
37 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66427615 |
38 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.61308879 |
39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.58939967 |
40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.58492811 |
41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58148263 |
42 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.54247380 |
43 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.52728591 |
44 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.50811559 |
45 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.50383236 |
46 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49766422 |
47 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.48733385 |
48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47083668 |
49 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.46049589 |
50 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.45880854 |
51 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.45568447 |
52 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.43828596 |
53 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.43732149 |
54 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.43263615 |
55 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.42449159 |
56 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.41425095 |
57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40655270 |
58 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.40123776 |
59 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.38901803 |
60 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.37290915 |
61 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34453648 |
62 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.32940890 |
63 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.29912198 |
64 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.28376691 |
65 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.26578085 |
66 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.26461240 |
67 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.20575240 |
68 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.17626526 |
69 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.17159949 |
70 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.15996370 |
71 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.14512930 |
72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14285539 |
73 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.13536547 |
74 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12931246 |
75 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.12600006 |
76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11640405 |
77 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.11336442 |
78 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.08923369 |
79 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.08857851 |
80 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08824717 |
81 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04585745 |
82 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04488228 |
83 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.04338182 |
84 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04081295 |
85 | MAF_26560356_Chip-Seq_TH1_Human | 1.03527052 |
86 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.03488641 |
87 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02980505 |
88 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.02704077 |
89 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01223521 |
90 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.00484766 |
91 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.00298358 |
92 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.99450329 |
93 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.99379856 |
94 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98308956 |
95 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.98139782 |
96 | UTX_26944678_Chip-Seq_JUKART_Human | 0.97754892 |
97 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97136593 |
98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96758113 |
99 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96427818 |
100 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94957795 |
101 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94848915 |
102 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.94104249 |
103 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93409747 |
104 | * STAT1_20625510_ChIP-Seq_HELA_Human | 0.93385287 |
105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93057862 |
106 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92554384 |
107 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.92266881 |
108 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91843223 |
109 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91828432 |
110 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.91566353 |
111 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91525175 |
112 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.91452480 |
113 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.91251783 |
114 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.91222086 |
115 | MYB_26560356_Chip-Seq_TH1_Human | 0.91026080 |
116 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90688996 |
117 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.90427188 |
118 | * MYB_26560356_Chip-Seq_TH2_Human | 0.89853132 |
119 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89777019 |
120 | MAF_26560356_Chip-Seq_TH2_Human | 0.89010821 |
121 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.88256142 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 4.26251650 |
2 | MP0010094_abnormal_chromosome_stability | 3.50980061 |
3 | MP0004957_abnormal_blastocyst_morpholog | 3.50022201 |
4 | MP0003111_abnormal_nucleus_morphology | 3.34479181 |
5 | MP0003077_abnormal_cell_cycle | 3.06982432 |
6 | MP0008057_abnormal_DNA_replication | 2.72910747 |
7 | MP0001835_abnormal_antigen_presentation | 2.61515423 |
8 | MP0008058_abnormal_DNA_repair | 2.59895562 |
9 | MP0002396_abnormal_hematopoietic_system | 2.53538381 |
10 | MP0000372_irregular_coat_pigmentation | 2.42090080 |
11 | MP0008007_abnormal_cellular_replicative | 2.41008365 |
12 | MP0010352_gastrointestinal_tract_polyps | 2.25164230 |
13 | MP0003763_abnormal_thymus_physiology | 2.18763721 |
14 | MP0000490_abnormal_crypts_of | 2.17107171 |
15 | MP0005058_abnormal_lysosome_morphology | 2.15973047 |
16 | MP0000685_abnormal_immune_system | 2.11897071 |
17 | MP0009333_abnormal_splenocyte_physiolog | 2.10577931 |
18 | MP0002139_abnormal_hepatobiliary_system | 2.10218974 |
19 | MP0003195_calcinosis | 2.08397607 |
20 | MP0000343_altered_response_to | 2.01046180 |
21 | MP0008932_abnormal_embryonic_tissue | 1.98324492 |
22 | MP0001800_abnormal_humoral_immune | 1.95089856 |
23 | MP0003786_premature_aging | 1.93901815 |
24 | MP0003436_decreased_susceptibility_to | 1.86358335 |
25 | MP0002398_abnormal_bone_marrow | 1.84114906 |
26 | MP0009785_altered_susceptibility_to | 1.81797051 |
27 | MP0009278_abnormal_bone_marrow | 1.78460580 |
28 | MP0001730_embryonic_growth_arrest | 1.78221608 |
29 | MP0000350_abnormal_cell_proliferation | 1.77718751 |
30 | MP0005671_abnormal_response_to | 1.76991748 |
31 | MP0002452_abnormal_antigen_presenting | 1.71435787 |
32 | MP0003191_abnormal_cellular_cholesterol | 1.65004498 |
33 | MP0005000_abnormal_immune_tolerance | 1.63553674 |
34 | MP0000689_abnormal_spleen_morphology | 1.63405606 |
35 | MP0002722_abnormal_immune_system | 1.63057525 |
36 | MP0005025_abnormal_response_to | 1.61616338 |
37 | MP0002723_abnormal_immune_serum | 1.60953392 |
38 | MP0002420_abnormal_adaptive_immunity | 1.60899920 |
39 | MP0001819_abnormal_immune_cell | 1.58916247 |
40 | MP0002019_abnormal_tumor_incidence | 1.54819913 |
41 | MP0010307_abnormal_tumor_latency | 1.52563194 |
42 | MP0000716_abnormal_immune_system | 1.51841585 |
43 | MP0003806_abnormal_nucleotide_metabolis | 1.51236007 |
44 | MP0002429_abnormal_blood_cell | 1.50231896 |
45 | MP0009840_abnormal_foam_cell | 1.49045100 |
46 | MP0001853_heart_inflammation | 1.48745095 |
47 | MP0002405_respiratory_system_inflammati | 1.44470574 |
48 | MP0000703_abnormal_thymus_morphology | 1.43709182 |
49 | MP0000313_abnormal_cell_death | 1.42478213 |
50 | MP0002837_dystrophic_cardiac_calcinosis | 1.42442525 |
51 | MP0002277_abnormal_respiratory_mucosa | 1.42086655 |
52 | MP0002148_abnormal_hypersensitivity_rea | 1.41582848 |
53 | MP0001790_abnormal_immune_system | 1.41300211 |
54 | MP0005387_immune_system_phenotype | 1.41300211 |
55 | MP0000858_altered_metastatic_potential | 1.40416923 |
56 | MP0004808_abnormal_hematopoietic_stem | 1.38060325 |
57 | MP0003186_abnormal_redox_activity | 1.36602247 |
58 | MP0009764_decreased_sensitivity_to | 1.35203303 |
59 | MP0003303_peritoneal_inflammation | 1.34093227 |
60 | MP0001545_abnormal_hematopoietic_system | 1.27379412 |
61 | MP0005397_hematopoietic_system_phenotyp | 1.27379412 |
62 | MP0002166_altered_tumor_susceptibility | 1.27224564 |
63 | MP0010155_abnormal_intestine_physiology | 1.26292379 |
64 | MP0002080_prenatal_lethality | 1.23983866 |
65 | MP0008260_abnormal_autophagy | 1.22976698 |
66 | MP0009379_abnormal_foot_pigmentation | 1.19235518 |
67 | MP0005166_decreased_susceptibility_to | 1.19096331 |
68 | MP0002419_abnormal_innate_immunity | 1.18736025 |
69 | MP0001533_abnormal_skeleton_physiology | 1.17972221 |
70 | MP0001697_abnormal_embryo_size | 1.16644869 |
71 | MP0002138_abnormal_hepatobiliary_system | 1.16120540 |
72 | MP0005380_embryogenesis_phenotype | 1.14299256 |
73 | MP0001672_abnormal_embryogenesis/_devel | 1.14299256 |
74 | MP0003646_muscle_fatigue | 1.14019607 |
75 | MP0002006_tumorigenesis | 1.10938499 |
76 | MP0005075_abnormal_melanosome_morpholog | 1.08874511 |
77 | MP0003075_altered_response_to | 1.08266027 |
78 | MP0001873_stomach_inflammation | 1.07017255 |
79 | MP0005084_abnormal_gallbladder_morpholo | 1.05755949 |
80 | MP0005023_abnormal_wound_healing | 1.05405027 |
81 | MP0001845_abnormal_inflammatory_respons | 1.05376946 |
82 | MP0003984_embryonic_growth_retardation | 1.04751289 |
83 | MP0003866_abnormal_defecation | 1.03626037 |
84 | MP0009697_abnormal_copulation | 1.02926142 |
85 | MP0002088_abnormal_embryonic_growth/wei | 1.02541458 |
86 | MP0006082_CNS_inflammation | 1.02163504 |
87 | MP0005464_abnormal_platelet_physiology | 1.00908289 |
88 | MP0005174_abnormal_tail_pigmentation | 0.98019688 |
89 | MP0005319_abnormal_enzyme/_coenzyme | 0.98018726 |
90 | MP0003172_abnormal_lysosome_physiology | 0.97188562 |
91 | MP0006054_spinal_hemorrhage | 0.97046751 |
92 | MP0000358_abnormal_cell_content/ | 0.95948466 |
93 | MP0002086_abnormal_extraembryonic_tissu | 0.93275550 |
94 | MP0005310_abnormal_salivary_gland | 0.92710167 |
95 | MP0005451_abnormal_body_composition | 0.92294230 |
96 | MP0008469_abnormal_protein_level | 0.90264159 |
97 | MP0003123_paternal_imprinting | 0.90029018 |
98 | MP0002254_reproductive_system_inflammat | 0.89193760 |
99 | MP0002085_abnormal_embryonic_tissue | 0.88044010 |
100 | MP0005076_abnormal_cell_differentiation | 0.87847027 |
101 | MP0005408_hypopigmentation | 0.84824177 |
102 | MP0000477_abnormal_intestine_morphology | 0.84147727 |
103 | MP0004947_skin_inflammation | 0.80471858 |
104 | MP0009765_abnormal_xenobiotic_induced | 0.80308034 |
105 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79327682 |
106 | MP0003724_increased_susceptibility_to | 0.79047721 |
107 | MP0008875_abnormal_xenobiotic_pharmacok | 0.78526845 |
108 | MP0005332_abnormal_amino_acid | 0.77314491 |
109 | MP0000371_diluted_coat_color | 0.77050573 |
110 | MP0004510_myositis | 0.76860541 |
111 | MP0002095_abnormal_skin_pigmentation | 0.75690776 |
112 | MP0004197_abnormal_fetal_growth/weight/ | 0.75554557 |
113 | MP0000609_abnormal_liver_physiology | 0.75424460 |
114 | MP0000598_abnormal_liver_morphology | 0.75216534 |
115 | MP0005330_cardiomyopathy | 0.74040870 |
116 | MP0003448_altered_tumor_morphology | 0.73792132 |
117 | MP0006036_abnormal_mitochondrial_physio | 0.73585205 |
118 | MP0002933_joint_inflammation | 0.72114526 |
119 | MP0002132_abnormal_respiratory_system | 0.71404782 |
120 | MP0005636_abnormal_mineral_homeostasis | 0.71317528 |
121 | MP0002084_abnormal_developmental_patter | 0.70305021 |
122 | MP0003656_abnormal_erythrocyte_physiolo | 0.69990578 |
123 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69687980 |
124 | MP0003718_maternal_effect | 0.69668253 |
125 | MP0003567_abnormal_fetal_cardiomyocyte | 0.69328470 |
126 | MP0008873_increased_physiological_sensi | 0.68856354 |
127 | MP0000015_abnormal_ear_pigmentation | 0.68408851 |
128 | MP0001764_abnormal_homeostasis | 0.68380112 |
129 | MP0009053_abnormal_anal_canal | 0.66844848 |
130 | MP0005266_abnormal_metabolism | 0.65475378 |
131 | MP0005621_abnormal_cell_physiology | 0.64929469 |
132 | MP0005165_increased_susceptibility_to | 0.64677260 |
133 | MP0005083_abnormal_biliary_tract | 0.64510921 |
134 | MP0006035_abnormal_mitochondrial_morpho | 0.64214556 |
135 | MP0005384_cellular_phenotype | 0.64090662 |
136 | MP0009763_increased_sensitivity_to | 0.63342217 |
137 | MP0000465_gastrointestinal_hemorrhage | 0.60252995 |
138 | MP0001293_anophthalmia | 0.58744713 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.98997572 |
2 | Reticulocytopenia (HP:0001896) | 4.90394572 |
3 | Abnormal number of erythroid precursors (HP:0012131) | 4.62046778 |
4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.36088713 |
5 | Acute necrotizing encephalopathy (HP:0006965) | 4.34158898 |
6 | Increased intramyocellular lipid droplets (HP:0012240) | 4.21940665 |
7 | Mitochondrial inheritance (HP:0001427) | 4.15648958 |
8 | Increased CSF lactate (HP:0002490) | 3.99782416 |
9 | Increased hepatocellular lipid droplets (HP:0006565) | 3.97126945 |
10 | Renal Fanconi syndrome (HP:0001994) | 3.86072528 |
11 | Acute encephalopathy (HP:0006846) | 3.84296938 |
12 | Increased muscle lipid content (HP:0009058) | 3.66480771 |
13 | Lipid accumulation in hepatocytes (HP:0006561) | 3.64959836 |
14 | Macrocytic anemia (HP:0001972) | 3.55731563 |
15 | Pallor (HP:0000980) | 3.55628682 |
16 | Hepatocellular necrosis (HP:0001404) | 3.46861045 |
17 | Hepatic necrosis (HP:0002605) | 3.37174260 |
18 | Birth length less than 3rd percentile (HP:0003561) | 3.35522371 |
19 | Progressive macrocephaly (HP:0004481) | 3.35146064 |
20 | Thrombocytosis (HP:0001894) | 3.33887019 |
21 | Oral leukoplakia (HP:0002745) | 3.22639556 |
22 | IgM deficiency (HP:0002850) | 3.19171883 |
23 | Respiratory difficulties (HP:0002880) | 3.15953933 |
24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.07780386 |
25 | Aplastic anemia (HP:0001915) | 3.06443870 |
26 | Cerebral edema (HP:0002181) | 3.01994133 |
27 | Lactic acidosis (HP:0003128) | 2.97968608 |
28 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.90605805 |
29 | Multiple enchondromatosis (HP:0005701) | 2.85744802 |
30 | Breast hypoplasia (HP:0003187) | 2.84337393 |
31 | Abnormality of T cell physiology (HP:0011840) | 2.80815524 |
32 | Ragged-red muscle fibers (HP:0003200) | 2.79491804 |
33 | Vacuolated lymphocytes (HP:0001922) | 2.78216266 |
34 | Microretrognathia (HP:0000308) | 2.75179477 |
35 | Poikiloderma (HP:0001029) | 2.68041621 |
36 | Degeneration of anterior horn cells (HP:0002398) | 2.67976178 |
37 | Abnormality of the anterior horn cell (HP:0006802) | 2.67976178 |
38 | Rough bone trabeculation (HP:0100670) | 2.67652930 |
39 | 11 pairs of ribs (HP:0000878) | 2.65639944 |
40 | Exercise intolerance (HP:0003546) | 2.65526275 |
41 | Selective tooth agenesis (HP:0001592) | 2.64480933 |
42 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.60566894 |
43 | Abnormality of T cells (HP:0002843) | 2.59712712 |
44 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.59388538 |
45 | Respiratory failure (HP:0002878) | 2.55244362 |
46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.52898509 |
47 | Abnormality of glycolipid metabolism (HP:0010969) | 2.52898509 |
48 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.52898509 |
49 | Trismus (HP:0000211) | 2.52818582 |
50 | Lymphoma (HP:0002665) | 2.46288275 |
51 | Poor head control (HP:0002421) | 2.45481366 |
52 | Combined immunodeficiency (HP:0005387) | 2.45279669 |
53 | Increased serum pyruvate (HP:0003542) | 2.43000449 |
54 | Recurrent bronchitis (HP:0002837) | 2.40372314 |
55 | Agnosia (HP:0010524) | 2.38957632 |
56 | Absent thumb (HP:0009777) | 2.38308022 |
57 | Recurrent abscess formation (HP:0002722) | 2.34345033 |
58 | IgG deficiency (HP:0004315) | 2.34194943 |
59 | Recurrent viral infections (HP:0004429) | 2.34047250 |
60 | Lethargy (HP:0001254) | 2.33285928 |
61 | Colon cancer (HP:0003003) | 2.31051185 |
62 | Recurrent skin infections (HP:0001581) | 2.30206862 |
63 | Abnormality of macrophages (HP:0004311) | 2.30028772 |
64 | Progressive muscle weakness (HP:0003323) | 2.29901579 |
65 | Abnormality of glycolysis (HP:0004366) | 2.28587605 |
66 | Increased cerebral lipofuscin (HP:0011813) | 2.28441835 |
67 | 3-Methylglutaconic aciduria (HP:0003535) | 2.27794121 |
68 | Cerebral hypomyelination (HP:0006808) | 2.26583487 |
69 | Abnormality of renal resorption (HP:0011038) | 2.26503147 |
70 | Abnormality of reticulocytes (HP:0004312) | 2.26441355 |
71 | Chromsome breakage (HP:0040012) | 2.26252262 |
72 | Autoimmune thrombocytopenia (HP:0001973) | 2.26082882 |
73 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.24882366 |
74 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.24882366 |
75 | Entropion (HP:0000621) | 2.23610010 |
76 | Acute hepatic failure (HP:0006554) | 2.23029729 |
77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.22750001 |
78 | Dicarboxylic aciduria (HP:0003215) | 2.22750001 |
79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.22657073 |
80 | Recurrent cutaneous fungal infections (HP:0011370) | 2.21988473 |
81 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.21988473 |
82 | Abnormal glycosylation (HP:0012345) | 2.21941321 |
83 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.21941321 |
84 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.21941321 |
85 | Abnormal protein glycosylation (HP:0012346) | 2.21941321 |
86 | Basal cell carcinoma (HP:0002671) | 2.20792815 |
87 | Premature graying of hair (HP:0002216) | 2.18366942 |
88 | Abnormality of the preputium (HP:0100587) | 2.16743469 |
89 | Cellular immunodeficiency (HP:0005374) | 2.16322233 |
90 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.15625750 |
91 | Severe combined immunodeficiency (HP:0004430) | 2.15157004 |
92 | Nausea (HP:0002018) | 2.13090593 |
93 | Generalized aminoaciduria (HP:0002909) | 2.11406480 |
94 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.11387553 |
95 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.11040159 |
96 | Abnormality of urine glucose concentration (HP:0011016) | 2.10339419 |
97 | Glycosuria (HP:0003076) | 2.10339419 |
98 | Myelodysplasia (HP:0002863) | 2.09480180 |
99 | Bone marrow hypocellularity (HP:0005528) | 2.09250103 |
100 | Abnormality of chromosome stability (HP:0003220) | 2.09141745 |
101 | Systemic lupus erythematosus (HP:0002725) | 2.08227796 |
102 | Methylmalonic aciduria (HP:0012120) | 2.08227789 |
103 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.08112677 |
104 | Neoplasm of the pancreas (HP:0002894) | 2.07897448 |
105 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.07770218 |
106 | Petechiae (HP:0000967) | 2.06835154 |
107 | Pancytopenia (HP:0001876) | 2.05849872 |
108 | Parakeratosis (HP:0001036) | 2.05521238 |
109 | Microvesicular hepatic steatosis (HP:0001414) | 2.04339322 |
110 | Recurrent bacterial skin infections (HP:0005406) | 2.03267458 |
111 | Hypertensive crisis (HP:0100735) | 2.02316735 |
112 | Recurrent fungal infections (HP:0002841) | 2.01576426 |
113 | Eczematoid dermatitis (HP:0000976) | 2.01396088 |
114 | Chronic otitis media (HP:0000389) | 2.01044183 |
115 | Encephalitis (HP:0002383) | 2.00910766 |
116 | Colitis (HP:0002583) | 2.00289814 |
117 | Hepatosplenomegaly (HP:0001433) | 2.00277060 |
118 | Meckel diverticulum (HP:0002245) | 1.99409265 |
119 | Meningitis (HP:0001287) | 1.98100160 |
120 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.97791134 |
121 | Cleft eyelid (HP:0000625) | 1.97714513 |
122 | Personality changes (HP:0000751) | 1.97542320 |
123 | Type I transferrin isoform profile (HP:0003642) | 1.96957735 |
124 | Carpal bone hypoplasia (HP:0001498) | 1.96304967 |
125 | Abnormality of B cell number (HP:0010975) | 1.95247257 |
126 | B lymphocytopenia (HP:0010976) | 1.95247257 |
127 | Premature ovarian failure (HP:0008209) | 1.93840178 |
128 | Amaurosis fugax (HP:0100576) | 1.93128838 |
129 | T lymphocytopenia (HP:0005403) | 1.92954182 |
130 | Abnormality of T cell number (HP:0011839) | 1.92793274 |
131 | Patellar aplasia (HP:0006443) | 1.92516470 |
132 | Pustule (HP:0200039) | 1.92348482 |
133 | Abnormality of the ileum (HP:0001549) | 1.91001565 |
134 | Lymphopenia (HP:0001888) | 1.90679548 |
135 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.90600772 |
136 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.90574302 |
137 | Progressive neurologic deterioration (HP:0002344) | 1.88176193 |
138 | Abnormal trabecular bone morphology (HP:0100671) | 1.87741482 |
139 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.87622469 |
140 | Increased IgM level (HP:0003496) | 1.86677147 |
141 | Leukopenia (HP:0001882) | 1.86616509 |
142 | Reduced antithrombin III activity (HP:0001976) | 1.86489136 |
143 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.84871688 |
144 | Granulocytopenia (HP:0001913) | 1.83919235 |
145 | Exertional dyspnea (HP:0002875) | 1.83826391 |
146 | Hyperphosphaturia (HP:0003109) | 1.81775904 |
147 | Increased serum lactate (HP:0002151) | 1.81204396 |
148 | Optic disc pallor (HP:0000543) | 1.81151000 |
149 | Cellulitis (HP:0100658) | 1.80090216 |
150 | Hypokinesia (HP:0002375) | 1.79856108 |
151 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.79093293 |
152 | Hyperglycinemia (HP:0002154) | 1.78479642 |
153 | Impulsivity (HP:0100710) | 1.78448318 |
154 | Increased serum ferritin (HP:0003281) | 1.78166515 |
155 | Cholecystitis (HP:0001082) | 1.77882052 |
156 | Abnormal gallbladder physiology (HP:0012438) | 1.77882052 |
157 | Orthostatic hypotension (HP:0001278) | 1.77539597 |
158 | Inflammation of the large intestine (HP:0002037) | 1.77494423 |
159 | Medulloblastoma (HP:0002885) | 1.77110482 |
160 | Abnormality of DNA repair (HP:0003254) | 1.76850342 |
161 | Panhypogammaglobulinemia (HP:0003139) | 1.76269638 |
162 | Stomatitis (HP:0010280) | 1.76256464 |
163 | Prolonged neonatal jaundice (HP:0006579) | 1.76163368 |
164 | Myoglobinuria (HP:0002913) | 1.76015350 |
165 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.74960783 |
166 | Prominent metopic ridge (HP:0005487) | 1.74608156 |
167 | Agammaglobulinemia (HP:0004432) | 1.74576968 |
168 | Tracheoesophageal fistula (HP:0002575) | 1.74373689 |
169 | Rhabdomyosarcoma (HP:0002859) | 1.71265115 |
170 | Chronic obstructive pulmonary disease (HP:0006510) | 1.71065193 |
171 | Obstructive lung disease (HP:0006536) | 1.71065193 |
172 | Ependymoma (HP:0002888) | 1.70603015 |
173 | Mediastinal lymphadenopathy (HP:0100721) | 1.70214524 |
Rank | Gene Set | Z-score |
---|---|---|
1 | VRK2 | 5.10606096 |
2 | BUB1 | 3.81387660 |
3 | NME2 | 3.50923246 |
4 | EIF2AK1 | 3.06349076 |
5 | WEE1 | 3.04184204 |
6 | CDC7 | 2.94448874 |
7 | MAP4K1 | 2.94183858 |
8 | TLK1 | 2.66187472 |
9 | TESK2 | 2.65780135 |
10 | SCYL2 | 2.20001645 |
11 | NEK2 | 2.13078135 |
12 | BLK | 2.12692388 |
13 | PDK2 | 2.08513198 |
14 | MAP3K10 | 1.97223753 |
15 | EIF2AK3 | 1.95921155 |
16 | STK16 | 1.88572060 |
17 | KDR | 1.72455765 |
18 | MAP4K2 | 1.70829600 |
19 | PIM2 | 1.68205878 |
20 | BRSK2 | 1.63405494 |
21 | RPS6KA4 | 1.58088642 |
22 | GRK6 | 1.56513814 |
23 | GRK7 | 1.55554566 |
24 | MUSK | 1.55362526 |
25 | MAP3K12 | 1.53729169 |
26 | ACVR1B | 1.53060112 |
27 | STK10 | 1.49694519 |
28 | SRPK1 | 1.48302161 |
29 | ZAP70 | 1.47240403 |
30 | TRIM28 | 1.35704710 |
31 | TESK1 | 1.35430283 |
32 | RPS6KB2 | 1.35392783 |
33 | TYK2 | 1.35306106 |
34 | DYRK3 | 1.34990712 |
35 | PLK1 | 1.34211113 |
36 | CDK7 | 1.31800649 |
37 | TBK1 | 1.30929330 |
38 | LRRK2 | 1.30504972 |
39 | AURKB | 1.26890404 |
40 | PASK | 1.26460518 |
41 | IRAK4 | 1.24722271 |
42 | MAP3K8 | 1.24277070 |
43 | NUAK1 | 1.23310521 |
44 | TTK | 1.21527735 |
45 | VRK1 | 1.21241426 |
46 | EPHA2 | 1.16649688 |
47 | SMG1 | 1.15618396 |
48 | IRAK3 | 1.15178419 |
49 | BMPR2 | 1.13981853 |
50 | TGFBR1 | 1.13823258 |
51 | PIM1 | 1.13410578 |
52 | PAK4 | 1.12766990 |
53 | MAP2K3 | 1.12417489 |
54 | ERN1 | 1.10845739 |
55 | MAP3K11 | 1.10472782 |
56 | RIPK4 | 1.09538931 |
57 | CDK4 | 1.07207420 |
58 | MAP3K5 | 1.05171349 |
59 | ATR | 1.05032080 |
60 | EEF2K | 1.04906762 |
61 | PLK4 | 1.01647736 |
62 | NEK1 | 1.01533408 |
63 | FLT3 | 0.99719961 |
64 | BRSK1 | 0.97726152 |
65 | TAOK3 | 0.96368379 |
66 | MAP3K14 | 0.96230728 |
67 | PKN2 | 0.95677586 |
68 | JAK3 | 0.94883812 |
69 | AURKA | 0.94523773 |
70 | BTK | 0.91850277 |
71 | STK4 | 0.91491865 |
72 | TAOK2 | 0.90335728 |
73 | DAPK3 | 0.90301075 |
74 | TSSK6 | 0.87364760 |
75 | DAPK1 | 0.86279694 |
76 | BCKDK | 0.83419437 |
77 | MATK | 0.81276399 |
78 | ARAF | 0.80875006 |
79 | MKNK1 | 0.80226624 |
80 | BRAF | 0.79084815 |
81 | PBK | 0.78248237 |
82 | TEC | 0.75226205 |
83 | SYK | 0.74971780 |
84 | CSF1R | 0.74627671 |
85 | IKBKB | 0.73682252 |
86 | KIT | 0.73443718 |
87 | ADRBK2 | 0.72801637 |
88 | CHEK2 | 0.71879535 |
89 | TXK | 0.69338188 |
90 | TGFBR2 | 0.66629070 |
91 | CHEK1 | 0.65335142 |
92 | ILK | 0.64787961 |
93 | MAP3K3 | 0.63197588 |
94 | TAF1 | 0.63124816 |
95 | TAOK1 | 0.62648613 |
96 | EIF2AK2 | 0.61419059 |
97 | MST4 | 0.61172983 |
98 | PAK1 | 0.60151898 |
99 | IKBKE | 0.59601819 |
100 | NEK9 | 0.58851330 |
101 | LYN | 0.57913263 |
102 | LIMK1 | 0.56998482 |
103 | MAPKAPK5 | 0.55689741 |
104 | JAK1 | 0.54532484 |
105 | CSNK2A2 | 0.54511246 |
106 | CSK | 0.53417976 |
107 | PRKCI | 0.52942246 |
108 | PLK3 | 0.52508723 |
109 | MKNK2 | 0.51445001 |
110 | TRIB3 | 0.51433942 |
111 | ZAK | 0.51354889 |
112 | CDK12 | 0.50919487 |
113 | LCK | 0.50205799 |
114 | CSNK2A1 | 0.50133683 |
115 | CDK2 | 0.48033560 |
116 | CHUK | 0.47579806 |
117 | IRAK1 | 0.47361799 |
118 | CSNK1G3 | 0.46603621 |
119 | FGR | 0.46006215 |
120 | MAPKAPK3 | 0.45639347 |
121 | MAP2K2 | 0.44931021 |
122 | MARK3 | 0.44796162 |
123 | RPS6KA5 | 0.42853027 |
124 | BMPR1B | 0.42819808 |
125 | ABL2 | 0.41619311 |
126 | FES | 0.41502665 |
127 | FGFR4 | 0.41215408 |
128 | ITK | 0.40257925 |
129 | NME1 | 0.39704291 |
130 | CDK6 | 0.39580370 |
131 | MELK | 0.37218206 |
132 | TNK2 | 0.34701631 |
133 | PRKCQ | 0.34332440 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 5.00799746 |
2 | Ribosome_Homo sapiens_hsa03010 | 4.28022292 |
3 | Mismatch repair_Homo sapiens_hsa03430 | 4.06738440 |
4 | Proteasome_Homo sapiens_hsa03050 | 3.35346815 |
5 | Base excision repair_Homo sapiens_hsa03410 | 2.98017525 |
6 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.74969420 |
7 | Spliceosome_Homo sapiens_hsa03040 | 2.70493899 |
8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.64589721 |
9 | Homologous recombination_Homo sapiens_hsa03440 | 2.64581900 |
10 | RNA polymerase_Homo sapiens_hsa03020 | 2.54391020 |
11 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.50476995 |
12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.37786708 |
13 | RNA transport_Homo sapiens_hsa03013 | 2.27564430 |
14 | Cell cycle_Homo sapiens_hsa04110 | 1.92004987 |
15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.89873087 |
16 | Sulfur relay system_Homo sapiens_hsa04122 | 1.76077663 |
17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.66368979 |
18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.64503350 |
19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.63229212 |
20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.59474700 |
21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.58416895 |
22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.55548668 |
23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.54730741 |
24 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.51979159 |
25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50863165 |
26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.47565579 |
27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.44084947 |
28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37957176 |
29 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.36784823 |
30 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.33183356 |
31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.30514379 |
32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28719005 |
33 | RNA degradation_Homo sapiens_hsa03018 | 1.23707390 |
34 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.17002458 |
35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.15627891 |
36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.12141345 |
37 | Protein export_Homo sapiens_hsa03060 | 1.06969496 |
38 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.06630690 |
39 | Basal transcription factors_Homo sapiens_hsa03022 | 1.05632836 |
40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.05339504 |
41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.05053612 |
42 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.04996675 |
43 | Legionellosis_Homo sapiens_hsa05134 | 1.01791035 |
44 | Purine metabolism_Homo sapiens_hsa00230 | 0.98426825 |
45 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.98302097 |
46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.98164323 |
47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98026530 |
48 | Lysosome_Homo sapiens_hsa04142 | 0.93680390 |
49 | Tuberculosis_Homo sapiens_hsa05152 | 0.91669629 |
50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88254076 |
51 | Measles_Homo sapiens_hsa05162 | 0.84830535 |
52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.83219745 |
53 | Peroxisome_Homo sapiens_hsa04146 | 0.81844725 |
54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80664006 |
55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79444963 |
56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.78079899 |
57 | Apoptosis_Homo sapiens_hsa04210 | 0.76618735 |
58 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76441744 |
59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.76414390 |
60 | Leishmaniasis_Homo sapiens_hsa05140 | 0.75569451 |
61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69506359 |
62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69149064 |
63 | Shigellosis_Homo sapiens_hsa05131 | 0.68612782 |
64 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.66660335 |
65 | Parkinsons disease_Homo sapiens_hsa05012 | 0.66303859 |
66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66228283 |
67 | Malaria_Homo sapiens_hsa05144 | 0.65517104 |
68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65042358 |
69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65018238 |
70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64900358 |
71 | Salmonella infection_Homo sapiens_hsa05132 | 0.64526857 |
72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62752871 |
73 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.62165470 |
74 | Phagosome_Homo sapiens_hsa04145 | 0.61848930 |
75 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60275172 |
76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59399472 |
77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57755644 |
78 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56842225 |
79 | Huntingtons disease_Homo sapiens_hsa05016 | 0.56834839 |
80 | Allograft rejection_Homo sapiens_hsa05330 | 0.56139814 |
81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.55856848 |
82 | Asthma_Homo sapiens_hsa05310 | 0.55805070 |
83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53541107 |
84 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51372666 |
85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48954875 |
86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48717085 |
87 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48599831 |
88 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.48295406 |
89 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.47526064 |
90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47367575 |
91 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.47267782 |
92 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.46533088 |
93 | Influenza A_Homo sapiens_hsa05164 | 0.46375746 |
94 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.46045684 |
95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.45826191 |
96 | Hepatitis B_Homo sapiens_hsa05161 | 0.45451121 |
97 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.45016080 |
98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44098429 |
99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.43759612 |
100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43064335 |
101 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.40767924 |
102 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40239790 |
103 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40051263 |
104 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.37879948 |
105 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.36389131 |
106 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35613355 |
107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35391318 |
108 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35307720 |
109 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35195950 |
110 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.34795775 |
111 | Other glycan degradation_Homo sapiens_hsa00511 | 0.33869711 |
112 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.33513050 |
113 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.31252759 |
114 | Pertussis_Homo sapiens_hsa05133 | 0.29693141 |
115 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.28839894 |
116 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.28318552 |
117 | Bladder cancer_Homo sapiens_hsa05219 | 0.27967770 |
118 | Alcoholism_Homo sapiens_hsa05034 | 0.27520022 |
119 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.26833552 |
120 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26820057 |
121 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.25978496 |
122 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.25520478 |
123 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.24487454 |
124 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.24113347 |
125 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24009487 |
126 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.22938724 |
127 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.22722222 |
128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22714177 |
129 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.21990980 |